Berend Houwen Memorial Lecture: ISLH Las Vegas May 2009: The pathogenesis and management of thrombotic microangiopathies

International Journal of Laboratory Hematology

Volumn 31, Issue 3, 2009, Pages 268-276

  Scully, M A ^b   MacHin, S J ^a,b  

^a University College London ^*  (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

ADAMTS 13 activity; Rituximab; Treatment with plasma exchange; TTP

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIPYRIDAMOLE; IMMUNOGLOBULIN G ANTIBODY; RITUXIMAB; STEROID; VINCRISTINE; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADD ON THERAPY; AUTOIMMUNE DISEASE; BONE MARROW TRANSPLANTATION; CLINICAL FEATURE; CLINICAL TRIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MICROANGIOPATHY; MORTALITY; PANCREATITIS; PATHOGENESIS; PLASMAPHERESIS; PREGNANCY; PRIORITY JOURNAL; REVIEW; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADAM PROTEINS; ADRENAL CORTEX HORMONES; ANTIBODIES, MONOCLONAL; HUMANS; IMMUNOLOGIC FACTORS; PURPURA, THROMBOTIC THROMBOCYTOPENIC; TUBULIN MODULATORS; VINCRISTINE;

EID: 65349092765     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2009.01159.x     Document Type: Review

References (33)

1. Cataland S.R., Jin M., Ferketich A.K., Kennedy M.S., Kraut E.H., George J.N. Wu H.M. (2007a) An evaluation of cyclosporin and corticosteroids individually as adjuncts to plasma exchange in the treatment of thrombotic thrombocytopenic purpura. British Journal of Haematology 136, 146 149.
2. Cataland S.R., Jin M., Lin S., Kennedy M.S., Kraut E.H., George J.N. Wu H.M. (2007b) Cyclosporin and plasma exchange in thrombotic thrombocytopenic purpura: long-term follow-up with serial analysis of ADAMTS13 activity. British Journal of Haematology 139, 486 493.
3. Fakhouri F., Vernant J.P., Veyradier A., Wolf M., Kaplanski G., Binaut R., Rieger M., Scheiflinger F., Poullin P., Deroure B., Delarue R., Lesavre P., Vanhille P., Hermine O., Remuzzi G. Grunfeld J.P. (2005) Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases. Blood 106, 1932 1937.
4. Fujikawa K., Suzuki H., McMullen B. Chung D. (2001) Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood 98, 1662 1666.
5. Fujimura Y., Matsumoto M., Kokame K., Isonishi A., Soejima K., Akiyama N., Tomiyama J., Natori K., Kuranishi Y., Imamura Y., Inoue N., Higasa S., Seike M., Kozuka T., Hara M., Wada H., Murata M., Ikeda Y., Miyata T. George J.N. (2008) Pregnancy-induced thrombocytopenia and TTP, and the risk of fetal death, in Upshaw-Schulman syndrome: a series of 15 pregnancies in 9 genotyped patients. British Journal of Haematology 144, 742 754.
6. Furlan M., Robles R. Lamie B. (1996) Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 87, 4223 4234.
7. Furlan M., Robles R., Solenthaler M., Wassmer M., Sandoz P. Lammle B. (1997) Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood 89, 3097 3103.
8. Furlan M., Robles R., Galbusera M., Remuzzi G., Kyrle P.A., Brenner B., Krause M., Scharrer I., Aumann V., Mittler U., Solenthaler M. Lammle B. (1998a) von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. The New England Journal of Medicine 339, 1578 1584.
9. Furlan M., Robles R., Solenthaler M. Lammle B. (1998b) Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura. Blood 91, 2839 2846.
10. Heidel F., Lipka D.B., von Auer C., Huber C., Scharrer I. Hess G. (2007) Addition of rituximab to standard therapy improves response rate and progression-free survival in relapsed or refractory thrombotic thrombocytopenic purpura and autoimmune haemolytic anaemia. Thrombosis and Haemostasis 97, 228 233.
11. Jasti S., Coyle T., Gentile T., Rosales L. Poiesz B. (2008) Rituximab as an adjunct to plasma exchange in TTP: a report of 12 cases and review of literature. Journal of Clinical Apheresis 23, 151 156.
12. Levy G.G., Nichols W.C., Lian E.C., Foroud T., McClintick J.N., McGee B.M., Yang A.Y., Siemieniak D.R., Stark K.R., Gruppo R., Sarode R., Shurin S.B., Chandrasekaran V., Stabler S.P., Sabio H., Bouhassira E.E., Upshaw J.D. Jr., Ginsburg D. Tsai H.M. (2001) Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413, 488 494.
13. Malak S., Wolf M., Millot G.A., Mariotte E., Veyradier A., Meynard J.L., Korach J.M., Malot S., Bussel A., Azoulay E., Boulanger E., Galicier L., Devaux E., Eschwege V., Gallien S., Adrie C., Schlemmer B., Rondeau E. Coppo P. (2008) Human immunodeficiency virus-associated thrombotic microangiopathies: clinical characteristics and outcome according to ADAMTS13 activity. Scandinavian Journal of Immunology 68, 337 344.
14. McDonald V., Laffan M., Benjamin S., Bevan D., Machin S. Scully M.A. (2008) Thrombotic thrombocytopenic purpura precipitated by acute pancreatitis: a report of seven cases from a regional UK TTP registry. British Journal of Haematology 144, 430 433.
15. Miller R.F., Scully M., Cohen H., Roedling S., Starke R., Edwards S.G. Machin S.J. (2005) Thrombotic thrombocytopaenic purpura in HIV-infected patients. International Journal of STD & AIDS 16, 538 542.
16. Moake J.L., Rudy C.K., Troll J.H., Weinstein M.J., Colannino N.M., Azocar J., Seder R.H., Hong S.L. Deykin D. (1982) Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic.
17. Peyvandi F., Ferrari S., Lavoretano S., Canciani M.T. Mannucci P.M. (2004) von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura. British Journal of Haematology 127, 433 439.
18. Peyvandi F., Siboni S.M., Lambertenghi D.D., Lavoretano S., De Fazio N., Moroni B., Lambertenghi D.G. Mannuccio M.P. (2006) Prospective study on the behaviour of the metalloprotease ADAMTS13 and of von Willebrand factor after bone marrow transplantation. British Journal of Haematology 134, 187 195.
19. Peyvandi F., Lavoretano S., Palla R., Feys H.B., Vanhoorelbeke K., Battaglioli T., Valsecchi C., Canciani M.T., Fabris F., Zver S., Reti M., Mikovic D., Karimi M., Giuffrida G., Laurenti L. Mannucci P.M. (2008) ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission. Haematologica 93, 232 239.
20. Rieger M., Mannucci P.M., Kremer Hovinga J.A., Herzog A., Gerstenbauer G., Konetschny C., Zimmermann K., Scharrer I., Peyvandi F., Galbusera M., Remuzzi G., Bohm M., Plaimauer B., Lammle B. Scheiflinger F. (2005) ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases. Blood 106, 1262 1267.
21. Rock G.A., Shumak K.H., Buskard N.A., Blanchette V.S., Kelton J.G., Nair R.C. Spasoff R.A. (1991) Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. The New England Journal of Medicine 325, 393 397.
22. Sanchez-Luceros A., Farias C.E., Amaral M.M., Kempfer A.C., Votta R., Marchese C., Salviu M.J., Woods A.I., Meschengieser S.S. Lazzari M.A. (2004) von Willebrand factor-cleaving protease (ADAMTS13) activity in normal non-pregnant women, pregnant and post-delivery women. Thrombosis and Haemostasis 92, 1320 1326.
23. Scheiflinger F., Knobl P., Trattner B., Plaimauer B., Mohr G., Dockal M., Dorner F. Rieger M. (2003) Nonneutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura. Blood 102, 3241 3243.
24. Scully M., Starke R., Lee R., Mackie I., Machin S. Cohen H. (2006) Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpura. Blood Coagulation & Fibrinolysis 17, 459 463.
25. Scully M., Cohen H., Cavenagh J., Benjamin S., Starke R., Killick S., Mackie I. Machin S.J. (2007) Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13. British Journal of Haematology 136, 451 461.
26. Scully M., Liesner R., Burgess C., Lawrie A. Machin S. (2008a) ADAMTS 13 in non-thrombotic thrombocytopaenic purpura conditions. British Journal of Haematology 141, 262 265.
27. Scully M., Yarranton H., Liesner R., Cavenagh J., Hunt B., Benjamin S., Bevan D., Mackie I. Machin S. (2008b) Regional UK TTP Registry: correlation with laboratory ADAMTS 13 analysis and clinical features. British Journal of Haematology 142, 819 826.
28. Terrell D.R., Williams L.A., Vesely S.K., Lammle B., Hovinga J.A. George J.N. (2005) The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency. Journal of Thrombosis and Haemostasis 3, 1432 1436.
29. Tsai H.M. (1996) Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood 87, 4235 4244.
30. Tsai H.M. Lian E.C. (1998) Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. The New England Journal of Medicine, 339, 1585 1594.
31. Vesely S.K., Li X., McMinn J.R., Terrell D.R. George J.N. (2004) Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion 44, 1149 1158.
32. Zheng X., Chung D., Takayama T.K., Majerus E.M., Sadler J.E. Fujikawa K. (2001) Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. The Journal of Biological Chemistry 276, 41059 41063.
33. Zheng X.L., Kaufman R.M., Goodnough L.T. Sadler J.E. (2004) Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura. Blood 103, 4043 4049.